NIPC Law

Douglas, Isle of Man Author: Zairon ;  Licence: CC BY 4.0 ; Source: Wikimedia Commons   Jane Lambert Intellectual Property Enterprise Court (Mr David Stone sitting as a Deputy Judge of the High Court)   DLP Limited v Coram UK Holding Limited . [2026] EWHC 2448 (IPEC) This was an action for the infringement of UK patent GB2446666 , a counterclaim for its revocation on the grounds of anticipation  and obviousness  and an application for its amendment.  The action and counterclaim came before Mr David Stone, sitting as a judge of the High Court on 21 and 22 July 2026.  He delivered judgment in DLP Limited v Coram UK Holding Limited [2026] EWHC 2448 on 25 Sept 2026.  By para [90] of that judgment, Mr Stone found the patent to be valid but not infringed.  He therefore dismissed both the claim and counterclaim. The Parties The claimant was DLP Limited ("DLP") , a Manx company specialising in the design, development and manufacture of products ...

Author RickDikeman   Licence CC BY-SA 3.0   Source Wikimedia Commons     Jane Lambert Patents Court (David Stone) Networld Sports Ltd v Quick Play Sport Ltd [2026] EWHC 1295 (Ch) (1 June 2026) This was an appeal by Networld Sports Ltd ("Networld") against the decision of Dr Benjamin Micklewright on behalf of the Comptroller General of Patents, Designs and Trade Marks of 14 Oct 2025 not to revoke claims 1 and 10 of  European patent (UK) 2 146 786 B1  on grounds of anticipation and obviousness.  The appeal was heard by Mr David Stone sitting as a deputy judge of the High Court on 9 March 2026.  Mr Stone handed down his judgment on 1 June 2026.  By para [43] of his judgment in  Networld Sports Ltd v Quick Play Sport Ltd [2026] EWHC 1295 (Ch) (1 June 2026), he dismissed Networld's appeal. The Invention The title of the patent was "Goal Apparatus".   It consisted of a  frame,  first and second flexible ...

Human Respiratory Syncytial Virus Author NIAID   Licence CC BY 2.0   Source    Wikimedia Commons   Jane Lambert Patents Court (Mr Justice Mellor)  Pfizer Ltd v GlaxoSmithKline Biologicals SA and another 2024] EWHC 2523 (Pat) (07 Oct 202 4) Pfizer Ltd v GlaxoSmithKline Biologicals SA and anothe r [2025] EWHC 52 (Pat) (16 Jan 2025) This was a claim by Pfizer Ltd. ("Pfizer")  for the revocation of  EP (UK) 3 109 258 ("258") and EP (UK) 2 222 710 ("710")  under s.72 (1) (a)  of the Patents Act 1977 on the grounds that the inventions for which those patents were granted were not patentable.  The patents were held by  GlaxoSmithKline Biologicals SA  and  ID Biomedical Corporation of Quebec  (collectively "GSK").   The reason for the litigation was that both Pfizer and GSK had developed vaccines for respiratory syncytial virus ("RSV")  that were about to receive marketing approval in the UK....